RESUMO
In 17 previously reported cases of cladosporiosis, no reliable therapy was described, and death occurred usually within one year of diagnosis. Pretreatment isolates from our two patients were inhibited by 6.2 mug/ml and 3.1mug/ml of flucytosine, respectively. Although both patients died, postmortem examination results showed that in one patient, the fungus had been eradicated. In the other patient, C trichoides that was isolated at postmortem examination was resistant to flucytosine treatment.
Assuntos
Abscesso Encefálico/etiologia , Cladosporium/isolamento & purificação , Fungos Mitospóricos/isolamento & purificação , Micoses/complicações , Adolescente , Adulto , Autopsia , Abscesso Encefálico/microbiologia , Abscesso Encefálico/patologia , Cladosporium/efeitos dos fármacos , Feminino , Flucitosina/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade , Micoses/patologiaRESUMO
Lung volume reduction surgery (LVRS) has recently been rediscovered and offers the potential of improving the quality of life of patients with advanced emphysema. In this article, we discuss the historical and contemporary versions of LVRS. Although initial enthusiasm has been substantial, existing data seem insufficient to demonstrate the safety and efficacy of the procedure in comparison with conventional medical therapy. Fundamental questions remain regarding the long-term effects of an operation versus medical therapy, the optimal selection criteria, the best measures of efficacy, the mechanisms of improvement, the cost-effectiveness of the procedure, and the optimal surgical technique. Until such questions are answered, advising patients about the best management their emphysema will be difficult. The National Emphysema Treatment Trial will address many of these issues and should be embraced by both health-care providers and patients.
Assuntos
Pneumonectomia/métodos , Enfisema Pulmonar/cirurgia , Volume Expiratório Forçado , Humanos , Transplante de Pulmão , Enfisema Pulmonar/mortalidade , Taxa de Sobrevida , Resultado do TratamentoRESUMO
Pulmonary disease in immunocompromised patients is common, but cavitary lung disease is less common and is usually associated with a fungal or mycobacterial infection. Pulmonary embolism is a noninfectious cause of a cavitary pulmonary process. Pulmonary embolism causes infarction in fewer than 15% of cases, and only about 5% of infarctions cavitate. Herein we describe two cases of cavitary infarcts in immunocompromised patients and review the clinical aspects of pulmonary infarcts and cavitation. Cavitary pulmonary infarction has been reported only rarely in immunocompromised patients. It is a dangerous but treatable pulmonary disease that must be considered in the differential diagnosis of immuno-compromised patients with lung disease.
Assuntos
Hospedeiro Imunocomprometido , Embolia Pulmonar/diagnóstico por imagem , Idoso , Feminino , Humanos , Pulmão/diagnóstico por imagem , Pessoa de Meia-Idade , Embolia Pulmonar/complicações , Embolia Pulmonar/imunologia , Tomografia Computadorizada por Raios XRESUMO
Tracheobronchial amyloidosis is characterized by deposits of amyloid in airway walls. No effective treatment is known. We describe a 59-year-old woman who presented with increasing symptoms of airway obstruction due to diffuse deposition of amyloid throughout her tracheobronchial tree. She was treated with external-beam radiation therapy (20 Gy) with marked improvement in her symptoms, effort tolerance, bronchoscopic appearance, and forced expiratory volume in 1 second (1.39 L to 1.97 L [42%]). This improvement was maintained during 21 months of follow-up.
Assuntos
Amiloidose/radioterapia , Broncopatias/radioterapia , Doenças da Traqueia/radioterapia , Amiloidose/patologia , Amiloidose/fisiopatologia , Broncopatias/patologia , Broncopatias/fisiopatologia , Broncoscopia , Fracionamento da Dose de Radiação , Tolerância ao Exercício , Feminino , Volume Expiratório Forçado , Humanos , Pessoa de Meia-Idade , Doenças da Traqueia/patologia , Doenças da Traqueia/fisiopatologia , Resultado do TratamentoRESUMO
Pulmonary lymphoproliferative disorders are a diverse group of conditions that primarily or secondarily involve the lungs. Modern diagnostic modalities, including immunologic and molecular genetics techniques, have contributed substantially to the continuously evolving understanding of these complex lesions. In this review, we classified pulmonary lymphoproliferative disorders into benign, intermediate or indeterminate, and malignant categories and described the clinical, radiographic, and pathologic features for the entire spectrum. Our emphasis is on the clinical findings and the role of tissue biopsy as well as ancillary techniques in diagnosis. Various treatments and expected responses are also discussed.
Assuntos
Pneumopatias , Transtornos Linfoproliferativos , Humanos , Pneumopatias/classificação , Pneumopatias/diagnóstico , Pneumopatias/imunologia , Pneumopatias/patologia , Transtornos Linfoproliferativos/classificação , Transtornos Linfoproliferativos/diagnóstico , Transtornos Linfoproliferativos/patologiaRESUMO
An unusual echocardiographic appearance of a cardiac echinococcal lesion confirmed intraoperatively is described in a patient with nonspecific cardiac complaints. Although previous reports have emphasized the echolucent, often multiseptated nature of echinococcal lesions, such characteristics were absent in this case. Thus, in the appropriate clinical setting, echinococcal infection should be included in the differential diagnosis of solid mass lesions of the heart because the surgical approach may need to be altered.
Assuntos
Equinococose/diagnóstico por imagem , Endocardite/diagnóstico por imagem , Endocardite/parasitologia , Adulto , Diagnóstico Diferencial , Equinococose/patologia , Equinococose/cirurgia , Ecocardiografia Transesofagiana , Endocardite/patologia , Endocardite/cirurgia , Feminino , HumanosRESUMO
Pulmonary hypertension (PH) with right-sided cardiac failure is a rare complication of amyloidosis, and its natural history is not well-defined. The aim of our study was to evaluate patients who were seen at our institution who had PH and amyloidosis and to describe the natural history of this complication. The study was a retrospective chart review of patients seen at the Mayo Clinic with both PH and amyloidosis listed as major diagnoses between January 1, 1980, and December 31, 1999. Patients with known causes of PH were excluded. Five patients met our criteria (four women and one man). Four patients had light-chain amyloidosis and one had amyloid A deposition secondary to familial Mediterranean fever. All patients had symptoms related to PH without echocardiographic evidence of left ventricular dysfunction. The median survival time after the diagnosis of amyloidosis was 2.8 years, and PH was found a median of 73 days before death. Five patients died of cardiac complications, including one with sudden cardiac death. PH is an unusual complication of amyloidosis. Patients develop PH late in the disease process and do not have a worse prognosis compared to other patients with cardiac amyloidosis. PH is a marker of advanced amyloidosis.
Assuntos
Amiloidose/complicações , Cardiomiopatias/complicações , Hipertensão Pulmonar/etiologia , Idoso , Idoso de 80 Anos ou mais , Amiloidose/diagnóstico , Cardiomiopatias/diagnóstico , Feminino , Humanos , Hipertensão Pulmonar/diagnóstico , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
Neurosarcoidosis occurs in approximately 5% of patients with systemic sarcoidosis. A review of medical literature shows that intracranial mass-like lesions secondary to sarcoidosis are quite rare. CT and MRI scanning would suggest that this manifestation of neurosarcoidosis may be more common than previously realized. We discuss five cases of neurosarcoidosis presenting as an intracranial mass. Empiric corticosteroid treatment can be recommended for cases with CNS mass in the context of systemic sarcoidosis.
Assuntos
Encefalopatias/etiologia , Sarcoidose/complicações , Sarcoidose/diagnóstico , Adulto , Meios de Contraste , Gadolínio DTPA , Humanos , Imageamento por Ressonância Magnética , Masculino , Compostos Organometálicos , Ácido Pentético/análogos & derivados , Tomografia Computadorizada por Raios XRESUMO
Metastatic spread to subcarinal lymph nodes in patients with bronchogenic carcinoma generally indicates unresectability. Transcarinal needle aspiration of the main carina (TCNA) has been used to obviate the need for more invasive procedures, particularly thoracic surgery. Of 510 transbronchial needle aspirations performed at our institution from 1983 to 1991, 88 (17 percent) were from the main carina in patients with bronchogenic carcinoma. We reviewed these 88 TCNA procedures to assess our experience with TCNA in the staging of lung cancer. The TCNA results were positive in 32 of 88 (36 percent) patients (20 non-small-cell cancers, 12 small-cell lung cancers). Following bronchoscopy, TCNA was the only evidence of unresectability in all 20 patients with non-small-cell lung cancer and was the only mode of diagnosis in 5 of 12 (42 percent) patients with small-cell lung cancer. Thirteen patients with non-small-cell lung cancer and positive TCNA also had positive bronchial secretion cytologic studies. Five of these patients had further subcarinal sampling and in all cases metastatic involvement was confirmed. TCNA was positive in 29 of 67 (43 percent) patients with radiographic evidence of mediastinal adenopathy. Of the remaining 38 patients with radiographic evidence of mediastinal adenopathy and negative TCNA results, 23 patients had further mediastinal sampling with mediastinoscopy or thoracotomy and in all cases mediastinal spread of cancer was established. Nineteen of 58 (33 percent) patients with an endoscopically normal-appearing main carina had a positive TCNA, while 13 of 30 (43 percent) patients with broadening or widening of the main carina had positive TCNA results. There were no complications. We conclude that TCNA is often a safe and useful staging modality in patients with bronchogenic carcinoma.
Assuntos
Carcinoma Broncogênico/patologia , Neoplasias Pulmonares/patologia , Pulmão/patologia , Biópsia por Agulha/métodos , Carcinoma Broncogênico/epidemiologia , Carcinoma Broncogênico/secundário , Humanos , Neoplasias Pulmonares/epidemiologia , Metástase Linfática , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Estudos RetrospectivosRESUMO
Epidemics of pulmonary blastomycosis have rarely been reported. The following epidemic occurred in a Minnesota family and several of their acquaintances after a canoeing trip in northwestern Wisconsin. The common exposure area was most likely a campsite, located along the upper reaches of the Namekagon River. The Namekagon River Valley is a known endemic area of Namekagon fever (blastomycosis) in dogs. Approximately one month after returning home, five of the eight members of the group had positive direct microscopic examinations and cultures of Blastomyces dermatitidis from their sputa, as well as abnormalities on their chest roentgenograms. Among these five patients, four were symptomatic, with fever, cough, and pleuritic chest pain. Of the three others, one had pleuritic chest pain with a transient lung infiltrate, the second was asymptomatic with a transient lung infiltrate, and the third was asymptomatic with a normal chest roentgenogram. Results of acute serologic tests (complement fixation and immunodiffusion) were negative in all five patients evaluated. None of the patients received antifungal therapy. Follow-up five years after the epidemic revealed that all eight were in excellent health, and none had evidence of continuing pulmonary or extrapulmonary disease.
Assuntos
Blastomicose/epidemiologia , Pneumopatias Fúngicas/epidemiologia , Adulto , Blastomicose/genética , Acampamento , Criança , Feminino , Humanos , Pneumopatias Fúngicas/genética , Masculino , Pessoa de Meia-Idade , WisconsinRESUMO
AIM: To investigate the potential association between the chronic myeloid disorders (CMDs), including the chronic myeloproliferative disorders, and pulmonary hypertension (PH). METHODS: Retrospective chart review of patients who had received diagnoses of both CMD and PH. Patients with a known cause of PH were excluded. The diagnosis of a CMD was based on established criteria. The diagnosis of PH was based on echocardiographic data or right heart catheterization data. RESULTS: Twenty-six patients satisfied the criteria for both a CMD and PH. Twelve patients had myeloid metaplasia with myelofibrosis (MMM), 5 patients had essential thrombocythemia (ET), 6 patients had polycythemia vera, 2 patients had a myelodysplastic syndrome, and 1 patient had chronic myeloid leukemia. Twenty-two patients (92%) received treatment for their CMDs, which included therapy with hydroxyurea (18 patients), anagrelide (7 patients), and busulfan (3 patients). PH was diagnosed a median of 8 years after recognition of the CMD (range, 0 to 26 years). The median right ventricular systolic pressure (RVsys) was 71 mm Hg (range, 32 to 105 mm Hg). RVsys correlated with the platelet count in patients with MMM (r = 0.30) and ET (r = 0.6) and with the hemoglobin levels in patients with PV (r = 0.77). Treatment of CMD did not seem to affect the severity of the pulmonary artery pressures as measured by serial echocardiography. With a median survival time of 18 months after the diagnosis of PH, the cause of death in the majority of the patients was cardiopulmonary. CONCLUSIONS: The current study suggests a higher than expected incidence of PH in patients with MMM, PV, and ET. Prognosis in such a setting is poor and may not be influenced by aggressive treatment of the underlying hematologic disorder.
Assuntos
Hipertensão Pulmonar/complicações , Transtornos Mieloproliferativos/complicações , Trombocitose/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , Cateterismo Cardíaco , Débito Cardíaco , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Policitemia Vera/complicações , Estudos RetrospectivosRESUMO
Pediatric tracheobronchial foreign bodies (PTBFBs) remain a significant cause of childhood morbidity and mortality. Because physicians do not always obtain a history of aspiration, and because the signs and symptoms of a PTBFB are nonspecific, diagnosis may be delayed, which increases the risk of complications when the foreign body is removed. Flexible fiberoptic and rigid bronchoscopy are often used in tandem for the identification and removal of PTBFBs. Recent advances in bronchoscopic equipment and technique have made removal of PTBFBs safer and more successful. Education of parents, child care providers, and medical personnel can reduce morbidity and mortality due to PTBFBs.